Phathom Pharmaceuticals (PHAT) Operating Leases (2022 - 2025)
Historic Operating Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $2.1 million.
- Phathom Pharmaceuticals' Operating Leases changed N/A to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $462000.0 for FY2023, which is 5792.35% down from last year.
- Per Phathom Pharmaceuticals' latest filing, its Operating Leases stood at $2.1 million for Q3 2025.
- Over the past 5 years, Phathom Pharmaceuticals' Operating Leases peaked at $2.1 million during Q3 2025, and registered a low of $133000.0 during Q2 2024.
- Moreover, its 4-year median value for Operating Leases was $867000.0 (2023), whereas its average is $898416.7.
- Per our database at Business Quant, Phathom Pharmaceuticals' Operating Leases tumbled by 8314.32% in 2024 and then skyrocketed by 34285.71% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' Operating Leases (Quarter) stood at $1.1 million in 2022, then plummeted by 57.92% to $462000.0 in 2023, then crashed by 71.21% to $133000.0 in 2024, then skyrocketed by 1496.24% to $2.1 million in 2025.
- Its Operating Leases was $2.1 million in Q3 2025, compared to $589000.0 in Q2 2025 and $133000.0 in Q2 2024.